No Association Between Human Immunodeficiency Virus Infections And Dementia: A Nationwide Cohort Study In Taiwan

References

• Taiwan Alzheimer`s Disease Association. 2015-2056 expected dementia population report in Taiwan; 2013; Available from: http://www.tada2002.org.tw/tada_know_02.html#01 Accessed 9, 10, 2014.
   Google Scholar
• Lin SJ, Kuo SC, Yang YH. Appeals system and its outcomes in national health insurance in Taiwan. Ann Pharmacother. 2006;40(3):506–511. doi:10.1345/aph.1G43716507607
   PubMed Web of Science ®Google Scholar
• Tzeng NS, Chang CW, Hsu JY, Chou YC, Chang HA, Kao YC. Caregiver burden for patients with dementia with or without hiring foreign health aides: a cross-sectional study in a northern taiwan memory clinic. J Med Sci. 2015;35(6):239–247. doi:10.4103/1011-4564.172999
   Google Scholar
• Tzeng NS, Chiang WS, Chen SY, et al. The impact of pharmacological treatments on cognitive function and severity of behavioral symptoms in geriatric elder patients with dementia. Taiwanese J Psychiatry. 2017;31(1):69–79.
   Google Scholar
• Wang HY, Chen JH, Huang SY, et al. Forensic evaluations for offenders with dementia in Taiwan’s criminal courts. J Am Acad Psychiatry Law. 2018;46(1):45–51.29618535
   PubMed Web of Science ®Google Scholar
• Zayyad Z, Spudich S. Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND). Curr HIV/AIDS Rep. 2015;12(1):16–24. doi:10.1007/s11904-014-0255-325604237
   PubMed Web of Science ®Google Scholar
• Price RW, Spudich SS, Peterson J, et al. Evolving character of chronic central nervous system HIV infection. Semin Neurol. 2014;34(1):7–13. doi:10.1055/s-0034-137233724715483
   PubMed Web of Science ®Google Scholar
• Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P. HIV-1 infection and cognitive impairment in the cART era: a review. AIDS. 2011;25(5):561–575. doi:10.1097/QAD.0b013e3283437f9a21160410
   PubMed Web of Science ®Google Scholar
• Rasmussen LD, May MT, Kronborg G, et al. Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study. Lancet HIV 2015;2(7):e288–e298. doi:10.1016/S2352-3018(15)00077-6
   Google Scholar
• Chiao S, Rosen HJ, Nicolas K, et al. Deficits in self-awareness impact the diagnosis of asymptomatic neurocognitive impairment in HIV. AIDS Res Hum Retroviruses. 2013;29(6):949–956. doi:10.1089/AID.2012.022923432363
   PubMed Web of Science ®Google Scholar
• Guaraldi G, Prakash M, Moecklinghoff C, Stellbrink H-J-JAR. Morbidity in older HIV-infected patients: impact of long-term antiretroviral use. AIDS Rev. 2014;16(2):75–89.24759453
   PubMed Web of Science ®Google Scholar
• Mills EJ, Barnighausen T, Negin J. HIV and aging–preparing for the challenges ahead. N Engl J Med. 2012;366(14):1270–1273. doi:10.1056/NEJMp111364322475591
   PubMed Web of Science ®Google Scholar
• Turner RS, Chadwick M, Horton WA, Simon GL, Jiang X, Esposito G. An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition. Alzheimers Dement (Amst). 2016;4:1–5. doi:10.1016/j.dadm.2016.03.00927489872
   PubMedGoogle Scholar
• Green DA, Masliah E, Vinters HV, Beizai P, Moore DJ, Achim CL. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS. 2005;19(4):407–411. doi:10.1097/01.aids.0000161770.06158.5c15750394
   PubMed Web of Science ®Google Scholar
• Achim CL, Adame A, Dumaop W, Everall IP, Masliah E. Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol. 2009;4(2):190–199. doi:10.1007/s11481-009-9152-819288297
   PubMed Web of Science ®Google Scholar
• Xu J, Ikezu T. The comorbidity of HIV-associated neurocognitive disorders and Alzheimer’s disease: a foreseeable medical challenge in post-HAART era. J Neuroimmune Pharmacol. 2009;4(2):200–212. doi:10.1007/s11481-008-9136-019016329
   PubMed Web of Science ®Google Scholar
• Levine AJ, Soontornniyomkij V, Achim CL, et al. Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV. J Neurovirol. 2016;22(4):431–441. doi:10.1007/s13365-015-0410-726637429
   PubMed Web of Science ®Google Scholar
• Underwood J, Robertson KR, Winston AJA. Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease? AIDS. 2015;29(3):253–261. doi:10.1097/QAD.000000000000053825426811
   PubMed Web of Science ®Google Scholar
• Lee CY, Jen IA, Lan YC, et al. AIDS incidence trends at presentation and during follow-up among HIV-at-risk populations: a 15-year nationwide cohort study in Taiwan. BMC Public Health. 2018;18(1):589. doi:10.1186/s12889-018-5500-z29720151
   PubMed Web of Science ®Google Scholar
• Taiwan Center for Diseases Control. HIV/AIDS; 2014 Available from: https://www.cdc.gov.tw/En/Category/ListContent/bg0g_VU_Ysrgkes_KRUDgQ?uaid=CqNo313w78G1fWhz429xDA Accessed 9, 11, 2019.
   Google Scholar
• Ho Chan WS. Taiwan’s healthcare report 2010. Epma J. 2010;1(4):563–585. doi:10.1007/s13167-010-0056-823199110
   PubMedGoogle Scholar
• Tzeng NS, Chung CH, Yeh CB, et al. Are chronic periodontitis and gingivitis associated with dementia? A nationwide, retrospective, matched-cohort study in Taiwan. Neuroepidemiology. 2016;47(2):82–93. doi:10.1159/00044916627618156
   PubMed Web of Science ®Google Scholar
• Tzeng NS, Chung CH, Liu FC, et al. Fibromyalgia and risk of dementia-a nationwide, population-based, cohort study. Am J Med Sci. 2018;355(2):153–161. doi:10.1016/j.amjms.2017.09.00229406043
   PubMed Web of Science ®Google Scholar
• Tzeng NS, Chung CH, Lin FH, et al. Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections-a nationwide, population-based cohort study in Taiwan. Neurother. 2018;15(2):417–429. doi:10.1007/s13311-018-0611-x
   PubMed Web of Science ®Google Scholar
• Cheng CL, Chien HC, Lee CH, Lin SJ, Yang YH. Validity of in-hospital mortality data among patients with acute myocardial infarction or stroke in National Health Insurance Research Database in Taiwan. Int J Cardiol. 2015;201:96–101. doi:10.1016/j.ijcard.2015.07.07526292275
   PubMed Web of Science ®Google Scholar
• Lin CC, Lai MS, Syu CY, Chang SC, Tseng FY. Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. J Formos Med Assoc. 2005;104(3):157–163.15818428
   PubMed Web of Science ®Google Scholar
• Li-Ting C, Chung-Ho C, Yi-Hsin Y, Pei-Shan H. The development and validation of oral cancer staging using administrative health data. BMC Cancer. 2014;14:380. doi:10.1186/1471-2407-14-38024884513
   PubMed Web of Science ®Google Scholar
• Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011;20(3):236–242. doi:10.1002/pds.208721351304
   PubMed Web of Science ®Google Scholar
• Sun Y, Lai MS, Lu CJ, Chen RC. How long can patients with mild or moderate Alzheimer’s dementia maintain both the cognition and the therapy of cholinesterase inhibitors: a national population-based study. Eur J Neurol. 2008;15(3):278–283. doi:10.1111/j.1468-1331.2007.02049.x18290848
   PubMed Web of Science ®Google Scholar
• Chang CY, Chen WL, Liou YF, et al. Increased risk of major depression in the three years following a femoral neck fracture–a national population-based follow-up study. PLoS One. 2014;9(3):e89867. doi:10.1371/journal.pone.008986724626193
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-83558716
   PubMedGoogle Scholar
• de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. a critical review of available methods. J Clin Epidemiol. 2003;56(3):221–229. doi:10.1016/s0895-4356(02)00585-112725876
   PubMed Web of Science ®Google Scholar
• Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–1251. doi:10.1016/0895-4356(94)90129-57722560
   PubMed Web of Science ®Google Scholar
• Mayeux R, Stern Y. Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2:8. doi:10.1101/cshperspect.a006239
   Web of Science ®Google Scholar
• Heaton RK, Clifford DB, Franklin DR Jr., et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology. 2010;75(23):2087–2096. doi:10.1212/WNL.0b013e318200d72721135382
   PubMed Web of Science ®Google Scholar
• Kinai E, Komatsu K, Sakamoto M, et al. Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study. J Neurovirol. 2017;23(6):864–874. doi:10.1007/s13365-017-0580-628971376
   PubMed Web of Science ®Google Scholar
• Blanquart F, Grabowski MK, Herbeck J, et al. A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda. Elife 2016;5:e20492.
   Google Scholar
• Fraser C, Hollingsworth TD, Chapman R, de Wolf F, Hanage WP. Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc Natl Acad Sci USA. 2007;104(44):17441–17446. doi:10.1073/pnas.0708559104
   Google Scholar
• Theys K, Libin P, Pineda-Pena AC, Nowe A, Vandamme AM, Abecasis AB. The impact of HIV-1 within-host evolution on transmission dynamics. Curr Opin Virol. 2018;28:92–101. doi:10.1016/j.coviro.2017.12.00129275182
   PubMed Web of Science ®Google Scholar
• Vrancken B, Baele G, Vandamme AM, van Laethem K, Suchard MA, Lemey P. Disentangling the impact of within-host evolution and transmission dynamics on the tempo of HIV-1 evolution. AIDS. 2015;29(12):1549–1556. doi:10.1097/QAD.000000000000073126244394
   PubMed Web of Science ®Google Scholar
• Alizon S, Hurford A, Mideo N, Van Baalen M. Virulence evolution and the trade-off hypothesis: history, current state of affairs and the future. J Evol Biol. 2009;22(2):245–259. doi:10.1111/j.1420-9101.2008.01658.x19196383
   PubMed Web of Science ®Google Scholar
• Valcour V, Shikuma C, Shiramizu B, et al. Higher frequency of dementia in older HIV-1 individuals: the Hawaii aging with HIV-1 cohort. Neurology. 2004;63(5):822–827. doi:10.1212/01.wnl.0000134665.58343.8d15365130
   PubMed Web of Science ®Google Scholar
• Chen MH, Su TP, Chen TJ, Cheng JY, Wei HT, Bai YM. Identification of psychiatric disorders among human immunodeficiency virus-infected individuals in Taiwan, a nine-year nationwide population-based study. AIDS Care. 2012;24(12):1543–1549. doi:10.1080/09540121.2012.67271622519868
   PubMed Web of Science ®Google Scholar
• Chakradhar S. A tale of two diseases: aging HIV patients inspire a closer look at Alzheimer’s disease. Nat Med. 2018;24(4):376–377. doi:10.1038/nm0418-37629634694
   PubMed Web of Science ®Google Scholar
• Heaton RK, Franklin DR, Ellis RJ, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17(1):3–16. doi:10.1007/s13365-010-0006-121174240
   PubMed Web of Science ®Google Scholar
• Vivithanaporn P, Heo G, Gamble J, et al. Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study. Neurology. 2010;75(13):1150–1158. doi:10.1212/WNL.0b013e3181f4d5bb20739646
   PubMed Web of Science ®Google Scholar
• Tsai YT, Chen YC, Hsieh CY, Ko WC, Ko NY. Incidence of neurological disorders among HIV-infected individuals with universal health care in Taiwan from 2000 to 2010. J Acquir Immune Defic Syndr. 2017;75(5):509–516. doi:10.1097/QAI.000000000000144828520614
   PubMed Web of Science ®Google Scholar
• Carvalhal A, Gill MJ, Letendre SL, et al. Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV treatment network cohort study. J Neurovirol. 2016;22(3):349–357.26572786
   PubMed Web of Science ®Google Scholar
• Sacktor N, Skolasky RL, Seaberg E, et al. Prevalence of HIV-associated neurocognitive disorders in the multicenter AIDS cohort study. Neurology. 2016;86(4):334–340. doi:10.1212/WNL.000000000000227726718568
   PubMed Web of Science ®Google Scholar
• Heikinheimo T, Poutiainen E, Salonen O, Elovaara I, Ristola M. Three-decade neurological and neurocognitive follow-up of HIV-1-infected patients on best-available antiretroviral therapy in Finland. BMJ Open. 2015;5(11):e007986. doi:10.1136/bmjopen-2015-007986
   Web of Science ®Google Scholar
• Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789–1799. doi:10.1212/01.WNL.0000287431.88658.8b17914061
   PubMed Web of Science ®Google Scholar
• Liu HC, Lin KN, Teng EL, et al. Prevalence and subtypes of dementia in Taiwan: a community survey of 5297 individuals. J Am Geriatr Soc. 1995;43(2):144–149. doi:10.1111/j.1532-5415.1995.tb06379.x7836638
   PubMed Web of Science ®Google Scholar
• Liu CK, Lai CL, Tai CT, Lin RT, Yen YY, Howng SL. Incidence and subtypes of dementia in southern Taiwan: impact of socio-demographic factors. Neurology. 1998;50(6):1572–1579. doi:10.1212/wnl.50.6.15729633696
   PubMed Web of Science ®Google Scholar
• Lin RT, Lai CL, Tai CT, Liu CK, Yen YY, Howng SL. Prevalence and subtypes of dementia in southern Taiwan: impact of age, sex, education, and urbanization. J Neurol Sci. 1998;160(1):67–75. doi:10.1016/s0022-510x(98)00225-19804120
   PubMed Web of Science ®Google Scholar